Kalin Katherine Bach
SEC CIK 1832671 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLS | SELLAS Life Sciences Group, Inc. | Dir | 154.4K | $136.8K | — | 6 | 2023-02-02 | 2026-01-07 |
Most active insiders at SLS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kalin Katherine Bach | Dir | $100.8K | — |
| 2 | Stergiou Angelos M. | Pres, CEO, Dir | — | — |
| 3 | Burns John Thomas | CFO | — | — |
| 4 | CICIC DRAGAN | SVP, Chief Development Off | — | — |
| 5 | Varian John | Dir | — | — |
| 6 | Wasman Jane | Dir | — | — |
| 7 | SCHEINBERG DAVID A | Dir | — | — |
| 8 | VAN NOSTRAND ROBERT L | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 | 2026-01-07 | SLS | SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +50.0K | 154.4K | +48% | $0 | |
| 2025-11-21 | 2025-11-19 | SLS | SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Dir | P - Purchase | $1.59 | +63.4K | 104.4K | +155% | +$100.8K | |
| 2025-05-22 | 2025-05-22 | SLS | SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Dir | P - Purchase | $1.80 | +20.0K | 41.0K | +95% | +$36.0K | |
| D | 2025-01-14 | 2025-01-10 | SLS | SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +12.5K | 21.0K | +147% | $0 |
| D | 2024-01-25 | 2024-01-22 | SLS | SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +6,000 | 8,500 | +240% | $0 |
| D | 2023-02-03 | 2023-02-02 | SLS | SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations